An experimental drug originally developed by Sanofi that is now being advanced by the Mayo Clinic significantly curbed ...

Mitral valve replacement in children traditionally uses non-living tissue or mechanical valves, neither of which grow as a ...

Journi Kelly, 11, needed a new heart. But her heart valves helped 2 other girls and allowed doctors to perform the 1st living ...

Heart Valve Disease Awareness Day, observed annually on February 22, is dedicated to educating the public about the risks, ...

An experimental drug being developed by Sanofi significantly curbed progression of aortic valve stenosis, a common heart ...

Researchers at Georgia Tech have developed 3D printed bioresorbably heart valves that could benefit patients with heart valve disease.

The new device created by researchers at Georgia Tech and Emory hopes to change the treatment of heart valve disease forever.

A study led by the University of Bristol, Bristol, England, has found that mechanical heart valves provide better long-term survival than biological heart valves in patients aged 50-70 years.

An experimental drug, ataciguat, initially created by Sanofi and further developed by the Mayo Clinic, has significantly ...